This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Comentario. El papel de las agencias reguladoras en la evaluación de la seguridad de los medicamentos: a propósito de los inhibidores selectivos de la recaptación de serotonina, Gaceta Sanitaria, October 2005, Elsevier,
DOI: 10.1157/13080142.
You can read the full text:
Be the first to contribute to this page
